STE Stock Analysis: Buy, Sell, or Hold?
STE - STERIS plc
$219.38
-0.02 (-0.01%)
▼
5d:
-0.73%
30d:
-13.07%
90d:
-14.11%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 13, 2026
Smart Money Accumulation
STE is down 11.0% this week, but smart money is accumulating calls. Top strike: $230 2026-04-17 with 4 OI. Call ratio: 80% View Scanner →
Strength: 8.5/10
Get Alerted When STE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: STE trading at deep discount. Market pricing in -5.0% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: STE trading at deep discount. Market pricing in -5.0% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$347.15
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$215.55
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STE is currently trading at $219.38, which is considered slightly low relative to its 30-day fair value range of $217.30 to $245.37. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.8) compared to its historical average (23.1). Remarkably, the market is currently pricing in an annual earnings decline of 5.0% over the next few years. This pessimistic expectation contrasts with the company's recent 12.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, STE is in a strong downtrend. The price is currently testing key support at $214.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $279.29 (+27.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STE is in a strong downtrend. The price is currently testing key support at $214.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $279.29 (+27.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$217.30 -
$245.37
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.3% below Wall St target ($279.29)
Fair Price Analysis
30-Day Fair Range
$217.30 -
$245.37
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$8.64
(3.9%)
Support & Resistance Levels
Support Level
$214.00
Resistance Level
$226.33
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.80
Wall Street Target
$279.29
(+27.3%)
Revenue Growth (YoY)
9.2%
Earnings Growth (YoY)
12.1%
Profit Margin
12.1%
Valuation Discount vs History
-5.0% cheaper
PE vs Historical
19.8 vs 23.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.0%
(market-implied from PE analysis)
1-Year Target
$208.41
(-5%)
2-Year Target
$197.99
(-10%)
3-Year Target
$188.09
(-14%)
3-Yr Target (if PE normalizes)
(PE: 20→23)
$219.42
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 8.6%)
$317.28
(+45%)
Base:
(SPY PE: 19.8, Growth: 8.6%)
$281.11
(+28%)
Bear:
(PE: 16.8, Growth: 8.6%)
$238.94
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 30.69 | Current EPS (TTM): $7.17
Bull Case
$374.62
(+70%)
Analyst growth 54.8%, PE expands to 33.8
Base Case
$340.56
(+54%)
Market implied 54.8%, PE stable at 30.7
Bear Case
$149.62
(-32%)
Severe decline -20.0%, PE contracts to 26.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.8 to 23.1
Stabilization Target:
$255.92
(+16.7%)
PE Expansion Potential:
+16.7%
Share & Embed Analysis
Last updated: March 30, 2026 6:31 PM ET
Data refreshes hourly during market hours. Next update: 7:31 PM
Data refreshes hourly during market hours. Next update: 7:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STE showing a specific setup today?
Insider Activity (6 Months)
3
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Cynthia L Feldmann
SELL
3098 shares
2026-03-05
Gilbert Ray Cisneros, Jr.
BUY
2026-02-10
April McClain Delaney
BUY
2026-02-06
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 48 HOLD |
Advanced STE Option Strategies
Professional options setups generated by AI based on today's STE price and gamma walls.
